Prolactin-induced expression of vascular endothelial growth factor via Egr-1.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  2005-03-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MCE.2005.01.005PMID 15737464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progestin-Dependent Induction of Vascular Endothelial Growth Factor in Human Breast Cancer Cells

  2004cited by this paper
• Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.

  2004cited by this paper
• Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins

  2004cited by this paper
• Angiogenesis and apoptosis.

  2003cited by this paper
• Transcription factor early growth response 1 activity up-regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblasts.

  2003cited by this paper
• Angiogenesis and white blood cell proliferation induced in mice by injection of a prolactin-expressing plasmid into muscle.

  2003cited by this paper
• Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein.

  2003cited by this paper
• Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis.

  2002cited by this paper
• Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

  2002cited by this paper
• Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells

  2002cited by this paper
• Antisense Egr‐1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injury

  2002cited by this paper
• Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells.

  2002cited by this paper
• Sp1 is required for prolactin activation of the interferon regulatory factor-1 gene.

  2001cited by this paper
• NSAIDs inhibit the activation of egr-1 gene in microvascular endothelial cells. A key to inhibition of angiogenesis?

  2001cited by this paper
• Fibroblast Growth Factor 2 Activation of Stromal Cell Vascular Endothelial Growth Factor Expression and Angiogenesis

  2001cited by this paper
• Vascular remodelling during the normal and malignant life cycle of the mammary gland

  2001cited by this paper
• Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cells during mouse mammary gland development.

  2001cited by this paper
• HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression

  2001cited by this paper
• The transcriptional corepressor NAB2 blocks Egr-1-mediated growth factor activation and angiogenesis.

  2001cited by this paper
• Identification of a Novel gp130-responsive Site in the Vasoactive Intestinal Peptide Cytokine Response Element*

  2000cited by this paper
• Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress

  2000cited by this paper
• Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques

  2000cited by this paper
• Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.

  2000cited by this paper
• Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner

  2000cited by this paper
• The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation.

  2000cited by this paper
• Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells.

  2000cited by this paper
• Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta.

  2000cited by this paper
• Structural and functional effects of high prolactin levels on injured endothelial cells

  2000cited by this paper
• Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

  1999cited by this paper
• Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis.

  1999cited by this paper
• Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.

  1999cited by this paper
• Role of sympathetic activity in controlling the expression of vascular endothelial growth factor in brown fat cells of lean and genetically obese rats

  1999cited by this paper
• Proteolysis of human prolactin: resistance to cathepsin D and formation of a nonangiostatic, C-terminal 16K fragment by thrombin.

  1999cited by this paper
• Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1.

  1999cited by this paper
• 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells.

  1999cited by this paper
• Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat

  1999cited by this paper
• Proteolysis of Human Prolactin: Resistance to Cathepsin D and Formation of a Nonangiostatic, C-Terminal 16K Fragment by Thrombin1.

  1999cited by this paper
• Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines

  1998cited by this paper
• Prolactin‐induced expression of TATA‐less cyclin D3 gene is mediated by Sp1 and AP2

  1998cited by this paper
• Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

  1998cited by this paper
• Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.

  1998cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Transforming growth factor‐α‐induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP‐2‐dependent DNA binding and transactivation

  1997cited by this paper
• Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression

  1997cited by this paper
• Induction of Sp1 activity by prolactin and interleukin-2 in Nb2 T-cells: differential association of Sp1-DNA complexes with Stats.

  1997cited by this paper
• The Mouse Gene for Vascular Endothelial Growth Factor

  1996cited by this paper
• Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.

  1996cited by this paper
• Egr-1-Induced Endothelial Gene Expression: A Common Theme in Vascular Injury

  1996cited by this paper
• Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis.

  1996cited by this paper
• A Regulatory Element in the Human Interleukin 2 Gene Promoter Is a Binding Site for the Zinc Finger Proteins Sp1 and EGR-1 (*)

  1995cited by this paper
• Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors.

  1995cited by this paper
• Prolactin synthesis and secretion by human breast cancer cells.

  1995cited by this paper
• Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

  1995cited by this paper
• Interplay of Sp1 and Egr-1 in the Proximal Platelet-derived Growth Factor A-Chain Promoter in Cultured Vascular Endothelial Cells (*)

  1995cited by this paper
• Activation of receptor-associated tyrosine kinase JAK2 by prolactin.

  1994cited by this paper
• Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression.

  1994cited by this paper
• Genomic sequencing.

  1993cited by this paper
• Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth.

  1993cited by this paper
• Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.

  1993cited by this paper
• The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.

  1993cited by this paper
• Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.

  1992cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells

  1990cited by this paper
• Prolactin regulation of beta‐casein gene expression and of a cytosolic 120‐kd protein in a cloned mouse mammary epithelial cell line.

  1988cited by this paper
• A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens.

  1987cited by this paper
• Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16K forms.

  1987cited by this paper
• Prolactin and breast cancer.

  1987cited by this paper
• Microvasculature of human micro- and macroprolactinomas. A morphological study.

  1986cited by this paper
• A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

  1986cited by this paper
• Genomic sequencing.

  1984cited by this paper
• Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line.

  1983cited by this paper
• The effect of prolonged dosage with oestrogens on the adult brown leghorn cock

  1939cited by this paper

• The Interplay of Prolactin with Inflammatory Nutritional Markers and NT-proBNP in Chronic Kidney Disease

  2025cites this paper
• Endocan levels in patients with hyperprolactinemia

  2025cites this paper
• Splenic Lymphatic Malformations: Clinical Characteristics of 35 Patients and Literature Review.

  2025cites this paper
• Canonical prolactin signaling and global mRNA expression in the skin of Holstein heifers carrying the SLICK1 allele of the prolactin receptor gene.

  2025cites this paper
• Developmental Competence of Oocytes Derived from Seasonally Anovulatory Mares Treated with Estradiol and Sulpiride

  2023cites this paper
• The interplay between prolactin and cardiovascular disease

  2023cites this paper
• Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding.

  2022cites this paper
• The Signaling Pathways Associated With Breast Cancer Bone Metastasis

  2022cites this paper
• Sex Differences in Renal Function: Participation of Gonadal Hormones and Prolactin

  2021cites this paper
• Polymorphisms of vascular endothelial growth factor and recurrent implantation failure: a systematic review and meta-analysis

  2021cites this paper
• Regulation of extracellular and intracellular prolactin on cell proliferation and survival rate through GHR/JAK2/STAT3 pathway in NSCLC.

  2020cites this paper
• Ochratoxin A triggered intracerebral hemorrhage in embryonic zebrafish: Involvement of microRNA-731 and prolactin receptor.

  2020cites this paper
• Prolactin and its receptor as therapeutic targets in glioblastoma multiforme

  2019cites this paper
• 23 – Mammary Gland

  2018cites this paper
• Physiopathology, Diagnosis, and Treatment of Hyperprolactinemia

  2018cites this paper
• BP1 Regulates PI3K/Akt Pathway by Targeting Vascular Endothelial Growth Factor (VEGF) in Breast Cancer

  2018cites this paper
• 5-HT1A Receptor Function Makes Wound Healing a Happier Process

  2018cites this paper
• Somatolactogens and diabetic retinopathy.

  2018cites this paper
• Hypothalamic-Pituitary Diseases

  2018cites this paper
• Association between vascular endothelial growth factor promoter polymorphisms and the risk of recurrent implantation failure.

  2017cites this paper
• What Is Breast in the Bone?

  2016cites this paper
• Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia.

  2016cites this paper
• The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview

  2016cites this paper
• Identification of resveratrol derivative 3,3',4,4',5,5'-hexamethoxy- trans-stilbene as a novel pro-angiogenic small-molecule compound.

  2016cites this paper
• Post-treatment with prolactin protects hippocampal CA1 neurons of the ovariectomized female rat against kainic acid-induced neurodegeneration.

  2016cites this paper
• Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population

  2016cites this paper
• Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos

  2016cites this paper
• Regulation and localization of vascular endothelial growth factor within the mammary glands during the transition from late gestation to lactation.

  2016cites this paper
• Mammary gland development--It's not just about estrogen.

  2016cites this paper
• JAK 2 / STAT and LKB 1 : an interaction linking PRL-mediated metabolic changes and structural integrity in MDA-MB-231 human breast cancer cells

  2015cites this paper
• The influence of hyperprolactinemia on coagulation parameters in females with prolactinomas.

  2014cites this paper
• JAK2/STAT and LKB1: An interaction linking PRL-mediated metabolic changes and structural integrity in MDA-MB-231 human breast cancer cells

  2014cites this paper
• The transcriptional responsiveness of LKB 1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells

  2014cites this paper
• The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells

  2014cites this paper
• Identification and characterization of microRNAs expressed in human breast cancer T-47D cells in response to prolactin treatment by Solexa deep-sequencing technology.

  2013cites this paper
• STAT5 and Prolactin Participate in a Positive Autocrine Feedback Loop That Promotes Angiogenesis*

  2013cites this paper
• Current treatment options for hyperprolactinemia

  2013cites this paper
• Targeting angiogenesis in the pathological ovary.

  2013cites this paper
• Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?

  2012cites this paper
• Stromal–epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer

  2012cites this paper
• Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function.

  2012cites this paper
• Prolactin and its 16-kDa N-terminal fragment: are higher in patients with precapillary pulmonary hypertension than in a healthy control group.

  2012cites this paper
• Prolactin and blood vessels: a comparative endocrinology perspective.

  2012cites this paper
• Trophic Actions of Prolactin in the Central Nervous System

  2012cites this paper
• Mechanisms of Platelet-Activating Factor-induced Enhancement of VEGF Expression

  2011cites this paper
• Low-dose aspirin therapy in IVF and ICSI patients

  2011cites this paper
• Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events.

  2011cites this paper
• Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck

  2011cites this paper
• Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP.

  2011cites this paper
• Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer

  2011cites this paper
• Expression von Prolaktin-Rezeptoren im kaninen gesunden Mammagewebe, in kaninen Mammaadenomen und Mammaadenokarzinomen

  2011cites this paper
• Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies

  2010cites this paper
• 16-kDa Prolactin Reduces Angiogenesis, but Not Growth of Human Breast Cancer Tumors In Vivo

  2010cites this paper
• Splenic lymphangiomatosis showing rapid growth during lactation: a case report.

  2010cites this paper
• The Mammary Gland Vasculature Revisited

  2010cites this paper
• Vascular Robo4 restricts proangiogenic VEGF signaling in breast

  2010cites this paper
• Prolactin—a novel neuroendocrine regulator of human keratin expression in situ

  2010cites this paper
• Elucidating the Tumor Suppressive Role of SLITs in Maintaining the Basal Cell Niche

  2009cites this paper
• Synergistic Effect of Dexamethasone and Prolactin on VEGF Expression in Bovine Mammary Epithelial Cells via p44/p42 MAP Kinase

  2009cites this paper
• Peptide hormone regulation of angiogenesis.

  2009influential citation
• Ulo ga pro lak ti na kod ra ka doj ke The ro le of pro lac tin in hu man brea st can cer

  2009cites this paper
• Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone.

  2009cites this paper
• Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.

  2009cites this paper
• Prolactin induces Egr-1 gene expression in cultured hypothalamic cells and in the rat hypothalamus.

  2009cites this paper
• The effects of endocrine and mechanical stimulation on stage I lactogenesis in bovine mammary epithelial cells.

  2008cites this paper
• Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b

  2008cites this paper
• Pregledni Članak Review

  2008cites this paper
• Role of Prolactin and Vasoinhibins in the Regulation of Vascular Function in Mammary Gland

  2008influential citation
• Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.

  2008cites this paper
• Historical Perspectives of Prolactin and Growth Hormone as Mammogens, Lactogens and Galactagogues—Agog for the Future!

  2008cites this paper
• The Gα12/13 Family of Heterotrimeric G Proteins and the Small GTPase RhoA Link the Kaposi Sarcoma-associated Herpes Virus G Protein-coupled Receptor to Heme Oxygenase-1 Expression and Tumorigenesis*

  2007cites this paper
• Prolactin-like hormone in the nematode Trichinella spiralis larvae.

  2007cites this paper
• A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

  2007cites this paper
• Prolactin and breast cancer risk.

  2006cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 141 Role of Islet Endothelial Cells in β-cell Function and Growth

  2006cites this paper
• Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ERDelta3.

  2006cites this paper
• Characterization of bovine early growth response factor-1 and its gonadotropin-dependent regulation in ovarian follicles prior to ovulation.

  2006cites this paper
• S179D prolactin primarily uses the extrinsic pathway and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells.

  2006cites this paper
• Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression.

  2006cites this paper
• Inhibition of Heme Oxygenase-1 Interferes with the Transforming Activity of the Kaposi Sarcoma Herpesvirusencoded G Protein-coupled Receptor*♦

  2006cites this paper
• A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone.

  2006cites this paper
• Update on endogenous inhibitors of angiogenesis.

  2006cites this paper
• Activation of vascular endothelial growth factor (VEGF) by the ER-α variant, ERΔ3

  2005cites this paper
• Abrogation of delayed type hypersensitivity response to Candida albicans produced by a molecular mimic of phosphorylated prolactin.

  2005cites this paper
• Odabrane teme iz biostatistike Lessons in biostatistics

  year unknowncites this paper